EVOSCRIPT Trademark

Trademark Overview

On Friday, September 18, 2015, a trademark application was filed for EVOSCRIPT with the United States Patent and Trademark Office. The USPTO has given the EVOSCRIPT trademark a serial number of 86760960. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, November 17, 2022. This trademark is owned by Roche Molecular Systems, Inc.. The EVOSCRIPT trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Complementary DNA (cDNA) synthesizing kits for medical purposes consisting of chemical reagents for cDNA synthesis for medical purposes

Chemical reagents for use in clinical and medical research laboratories for scientific and research purposes; polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR) reagents for scientific and medical research purposes; reagents for gene expression quantification for scientific and medical research purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; biological enzymes used for clinical or medical laboratory use
evoscript

General Information

Serial Number86760960
Word MarkEVOSCRIPT
Filing DateFriday, September 18, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, November 17, 2022
Registration Number5125375
Registration DateTuesday, January 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2016

Trademark Statements

Goods and ServicesComplementary DNA (cDNA) synthesizing kits for medical purposes consisting of chemical reagents for cDNA synthesis for medical purposes
Pseudo MarkEVO SCRIPT
Goods and ServicesChemical reagents for use in clinical and medical research laboratories for scientific and research purposes; polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR) reagents for scientific and medical research purposes; reagents for gene expression quantification for scientific and medical research purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; biological enzymes used for clinical or medical laboratory use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2015
Primary Code001
First Use Anywhere DateFriday, October 14, 2016
First Use In Commerce DateFriday, October 14, 2016
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2015
Primary Code005
First Use Anywhere DateFriday, October 14, 2016
First Use In Commerce DateFriday, October 14, 2016

Trademark Owner History

Party NameRoche Molecular Systems, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588
Party NameRoche Molecular Systems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588
Party NameRoche Molecular Systems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94588

Trademark Events

Event DateEvent Description
Wednesday, January 6, 2016ASSIGNED TO EXAMINER
Tuesday, September 22, 2015NEW APPLICATION ENTERED
Tuesday, September 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 23, 2015NOTICE OF PSEUDO MARK E-MAILED
Wednesday, January 13, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, January 13, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 13, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, January 13, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 22, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2016ASSIGNED TO LIE
Monday, February 29, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 5, 2016PUBLISHED FOR OPPOSITION
Thursday, December 15, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 31, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, November 22, 2016SOU EXTENSION 1 FILED
Tuesday, November 22, 2016SOU EXTENSION 1 GRANTED
Thursday, November 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 28, 2016TEAS STATEMENT OF USE RECEIVED
Monday, November 28, 2016USE AMENDMENT FILED
Thursday, December 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 2, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 19, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, October 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, December 16, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 17, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, November 27, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, May 12, 2022TEAS SECTION 8 & 15 RECEIVED
Thursday, November 17, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 17, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

evoscript medical purposes research reagents scientific cdna chemical complementary synthesis clinical